Exploring the Mechanisms of Modified Bu-Shen-Yi-Qi Decoction for COPD-Related Osteoporosis Therapy via Transcriptomics and Network Pharmacology Approach

References

• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
   PubMed Web of Science ®Google Scholar
• Lehouck A, Boonen S, Decramer M, Janssens W. COPD, bone metabolism, and osteoporosis. Chest. 2011;139(3):648–657. doi:10.1378/chest.10-1427
   PubMed Web of Science ®Google Scholar
• Decramer M, Rennard S, Troosters T, et al. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention. Copd. 2008;5(4):235–256. doi:10.1080/15412550802237531
   PubMedGoogle Scholar
• Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med. 2013;1(1):73–83. doi:10.1016/S2213-2600(12)70060-7
   PubMed Web of Science ®Google Scholar
• Bolton CE, Ionescu AA, Shiels KM, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(12):1286–1293. doi:10.1164/rccm.200406-754OC
   PubMed Web of Science ®Google Scholar
• Sabit R, Bolton CE, Edwards PH, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(12):1259–1265. doi:10.1164/rccm.200701-067OC
   PubMed Web of Science ®Google Scholar
• Dam TT, Harrison S, Fink HA, Ramsdell J, Barrett-Connor E. Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma. Osteoporos Int. 2010;21(8):1341–1349. doi:10.1007/s00198-009-1076-x
   PubMed Web of Science ®Google Scholar
• Chen SJ, Liao WC, Huang KH, et al. Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study. QJM. 2015;108(8):633–640. doi:10.1093/qjmed/hcv012
   PubMed Web of Science ®Google Scholar
• Kjensli A, Mowinckel P, Ryg MS, Falch JA. Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone. 2007;40(2):493–497. doi:10.1016/j.bone.2006.09.005
   PubMed Web of Science ®Google Scholar
• Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med. 2012;12:26. doi:10.1186/1471-2466-12-26
   PubMed Web of Science ®Google Scholar
• Ryan CS, Petkov VI, Adler RA. Osteoporosis in men: the value of laboratory testing. Osteoporos Int. 2011;22(6):1845–1853. doi:10.1007/s00198-010-1421-0
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev. 2004;56(4):515–548. doi:10.1124/pr.56.4.2
   PubMed Web of Science ®Google Scholar
• Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005;115(12):3318–3325. doi:10.1172/JCI27071
   PubMed Web of Science ®Google Scholar
• Watanabe R, Tanaka T, Aita K, et al. Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function. J Bone Miner Metab. 2015;33(4):392–400. doi:10.1007/s00774-014-0605-7
   PubMed Web of Science ®Google Scholar
• Tsukamoto M, Mori T, Wang KY, et al. Systemic bone loss, impaired osteogenic activity and type I muscle fiber atrophy in mice with elastase-induced pulmonary emphysema: establishment of a COPD-related osteoporosis mouse model. Bone. 2019;120:114–124. doi:10.1016/j.bone.2018.10.017
   PubMed Web of Science ®Google Scholar
• Sarkar M, Bhardwaj R, Madabhavi I, Khatana J. Osteoporosis in chronic obstructive pulmonary disease. Clin Med Insights Circ Respir Pulm Med. 2015;9:5–21. doi:10.4137/CCRPM.S22803
   PubMed Web of Science ®Google Scholar
• Graat-Verboom L, van den Borne BE, Smeenk FW, Spruit MA, Wouters EF. Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J Bone Miner Res. 2011;26(3):561–568. doi:10.1002/jbmr.257
   PubMed Web of Science ®Google Scholar
• Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393(10169):364–376. doi:10.1016/S0140-6736(18)32112-3
   PubMed Web of Science ®Google Scholar
• Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science. 2000;289(5484):1508–1514. doi:10.1126/science.289.5484.1508
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhang P, Zhang X, Lv L, Zhou Y. Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis. Cell Prolif. 2021;54(1):e12956. doi:10.1111/cpr.12956
   PubMed Web of Science ®Google Scholar
• Jiang TM. Identification of the genetic central dogma in osteogenic differentiation of MSCs by osteoinductive medium from transcriptional data sets. Chronic Dis Transl Med. 2022;8(3):218–228. doi:10.1002/cdt3.26
   PubMedGoogle Scholar
• Kong DX, Li XJ, Zhang HY. Where is the hope for drug discovery? Let history tell the future. Drug Discov Today. 2009;14(3–4):115–119. doi:10.1016/j.drudis.2008.07.002
   PubMed Web of Science ®Google Scholar
• Cheung F. TCM: made in China. Nature. 2011;480(7378):S82–83. doi:10.1038/480S82a
   PubMed Web of Science ®Google Scholar
• Zhong Y, Luo J, Tang T, et al. Exploring pharmacological mechanisms of Xuefu Zhuyu decoction in the treatment of traumatic brain injury via a network pharmacology approach. Evid Based Complementary Altern Med. 2018;2018:8916938. doi:10.1155/2018/8916938
   PubMed Web of Science ®Google Scholar
• Cui J, Xu F, Tang Z, et al. Bu-Shen-Yi-Qi formula ameliorates airway remodeling in murine chronic asthma by modulating airway inflammation and oxidative stress in the lung. Biomed Pharmacother. 2019;112:108694. doi:10.1016/j.biopha.2019.108694
   PubMed Web of Science ®Google Scholar
• Wei Y, Luo QL, Sun J, Chen MX, Liu F, Dong JC. Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model. J Ethnopharmacol. 2015;164:368–377. doi:10.1016/j.jep.2015.01.016
   PubMed Web of Science ®Google Scholar
• Wang G, Liu B, Cao Y, et al. Effects of two Chinese herbal formulae for the treatment of moderate to severe stable chronic obstructive pulmonary disease: a multicenter, double-blind, randomized controlled trial. PLoS One. 2014;9(8):e103168. doi:10.1371/journal.pone.0103168
   PubMed Web of Science ®Google Scholar
• Kong L, Zhang H, Cao Y, et al. The anti-inflammatory effects of invigorating kidney and supplementing Qi Chinese Herbal formulae in asthma patients. Evid Based Complementary Altern Med. 2017;2017:3754145. doi:10.1155/2017/3754145
   PubMed Web of Science ®Google Scholar
• Kong Q, Mo S, Wang W, et al. Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial. Trials. 2020;21(1):760. doi:10.1186/s13063-020-04669-5
   PubMedGoogle Scholar
• Wang Y, Zhang S, Li F, et al. Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics. Nucleic Acids Res. 2020;48(D1):D1031–d1041. doi:10.1093/nar/gkz981
   PubMed Web of Science ®Google Scholar
• Davis AP, Grondin CJ, Johnson RJ, et al. Comparative Toxicogenomics Database (CTD): update 2021. Nucleic Acids Res. 2021;49(D1):D1138–d1143. doi:10.1093/nar/gkaa891
   PubMed Web of Science ®Google Scholar
• Piñero J, Ramírez-Anguita JM, Saüch-Pitarch J, et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 2020;48(D1):D845–d855. doi:10.1093/nar/gkz1021
   PubMed Web of Science ®Google Scholar
• Fang S, Dong L, Liu L, et al. HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Res. 2021;49(D1):D1197–d1206. doi:10.1093/nar/gkaa1063
   PubMed Web of Science ®Google Scholar
• Hecker N, Ahmed J, von Eichborn J, et al. SuperTarget goes quantitative: update on drug-target interactions. Nucleic Acids Res. 2012;40:D1113–1117. doi:10.1093/nar/gkr912
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47(W1):W357–w364. doi:10.1093/nar/gkz382
   PubMed Web of Science ®Google Scholar
• Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK. Relating protein pharmacology by ligand chemistry. Nat Biotechnol. 2007;25(2):197–206. doi:10.1038/nbt1284
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Santos A, von Mering C, Jensen LJ, Bork P, Kuhn M. STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Res. 2016;44(D1):D380–384. doi:10.1093/nar/gkv1277
   PubMed Web of Science ®Google Scholar
• Wang X, Shen Y, Wang S, et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017;45(W1):W356–w360. doi:10.1093/nar/gkx374
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi:10.1101/gr.1239303
   PubMed Web of Science ®Google Scholar
• Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. doi:10.1038/nprot.2008.211
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. doi:10.1038/s41467-019-09234-6
   PubMed Web of Science ®Google Scholar
• Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27–31. doi:10.4103/0976-0105.177703
   PubMedGoogle Scholar
• Zhang H, Liu B, Jiang S, et al. Baicalin ameliorates cigarette smoke-induced airway inflammation in rats by modulating HDAC2/NF-κB/PAI-1 signalling. Pulm Pharmacol Ther. 2021;70:102061. doi:10.1016/j.pupt.2021.102061
   PubMed Web of Science ®Google Scholar
• Li Q, Wang G, Xiong SH, et al. Bu-Shen-Fang-Chuan formula attenuates cigarette smoke-induced inflammation by modulating the PI3K/Akt-Nrf2 and NF-κB signalling pathways. J Ethnopharmacol. 2020;261:113095. doi:10.1016/j.jep.2020.113095
   PubMed Web of Science ®Google Scholar
• Wang G, Mohammadtursun N, Sun J, et al. Establishment and evaluation of a rat model of sidestream cigarette smoke-induced chronic obstructive pulmonary disease. Front Physiol. 2018;9:58. doi:10.3389/fphys.2018.00058
   PubMed Web of Science ®Google Scholar
• Shen HH, Wang K, Li W, et al. Astragalus Membranaceus prevents airway hyperreactivity in mice related to Th2 response inhibition. J Ethnopharmacol. 2008;116(2):363–369. doi:10.1016/j.jep.2007.12.002
   PubMed Web of Science ®Google Scholar
• Song X, Wang C, Bai C. Establishment of rat chronic obstructive pulmonary disease model: a comparison between exposure to cigarette smoke alone and in combination with intra-tracheal injection of lipopolysaccharide. Acad J Second Mil Med Univ. 2010;31(03):246–249.
   Google Scholar
• Fukuoka H, Aoyama M, Miyazawa K, Asai K, Goto S. Hypoxic stress enhances osteoclast differentiation via increasing IGF2 production by non-osteoclastic cells. Biochem Biophys Res Commun. 2005;328(4):885–894. doi:10.1016/j.bbrc.2005.01.042
   PubMed Web of Science ®Google Scholar
• Liu H, Liu Y, Viggeswarapu M, Zheng Z, Titus L, Boden SD. Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor. J Bone Miner Res. 2011;26(5):1122–1132. doi:10.1002/jbmr.296
   PubMed Web of Science ®Google Scholar
• Matsushita T, Chan YY, Kawanami A, Balmes G, Landreth GE, Murakami S. Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis. Mol Cell Biol. 2009;29(21):5843–5857. doi:10.1128/MCB.01549-08
   PubMed Web of Science ®Google Scholar
• Lai CF, Cheng SL. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells. J Biol Chem. 2002;277(18):15514–15522. doi:10.1074/jbc.M200794200
   PubMed Web of Science ®Google Scholar
• Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res. 2003;18(11):2060–2068. doi:10.1359/jbmr.2003.18.11.2060
   PubMed Web of Science ®Google Scholar
• Nöth U, Tuli R, Seghatoleslami R, et al. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res. 2003;291(1):201–211. doi:10.1016/S0014-4827(03)00386-0
   PubMed Web of Science ®Google Scholar
• Caverzasio J, Manen D. Essential role of Wnt3a-mediated activation of mitogen-activated protein kinase p38 for the stimulation of alkaline phosphatase activity and matrix mineralization in C3H10T1/2 mesenchymal cells. Endocrinology. 2007;148(11):5323–5330. doi:10.1210/en.2007-0520
   PubMed Web of Science ®Google Scholar
• Chang J, Sonoyama W, Wang Z, et al. Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. J Biol Chem. 2007;282(42):30938–30948. doi:10.1074/jbc.M702391200
   PubMed Web of Science ®Google Scholar
• Rey A, Manen D, Rizzoli R, Ferrari SL, Caverzasio J. Evidences for a role of p38 MAP kinase in the stimulation of alkaline phosphatase and matrix mineralization induced by parathyroid hormone in osteoblastic cells. Bone. 2007;41(1):59–67. doi:10.1016/j.bone.2007.02.031
   PubMed Web of Science ®Google Scholar
• Bianchi EN, Ferrari SL. Beta-arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFkappaB gene expression network in osteoblasts. Bone. 2009;45(4):716–725. doi:10.1016/j.bone.2009.06.020
   PubMed Web of Science ®Google Scholar
• Suzuki A, Palmer G, Bonjour JP, Caverzasio J. Regulation of alkaline phosphatase activity by p38 MAP kinase in response to activation of Gi protein-coupled receptors by epinephrine in osteoblast-like cells. Endocrinology. 1999;140(7):3177–3182. doi:10.1210/endo.140.7.6857
   PubMed Web of Science ®Google Scholar
• Heron-Milhavet L, Khouya N, Fernandez A, Lamb NJ. Akt1 and Akt2: differentiating the aktion. Histol Histopathol. 2011;26(5):651–662. doi:10.14670/HH-26.651
   PubMed Web of Science ®Google Scholar
• Hers I, Vincent EE, Tavaré JM. Akt signalling in health and disease. Cell Signal. 2011;23(10):1515–1527. doi:10.1016/j.cellsig.2011.05.004
   PubMed Web of Science ®Google Scholar
• Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 2002;14(5):381–395. doi:10.1016/S0898-6568(01)00271-6
   PubMed Web of Science ®Google Scholar
• Rönnstrand L. Signal transduction via the stem cell factor receptor/c-Kit. Cell Mol Life Sci. 2004;61(19–20):2535–2548. doi:10.1007/s00018-004-4189-6
   PubMed Web of Science ®Google Scholar
• Bozinovski S, Vlahos R, Hansen M, Liu K, Anderson GP. Akt in the pathogenesis of COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(1):31–38. doi:10.2147/copd.2006.1.1.31
   PubMedGoogle Scholar
• Jones RG, Parsons M, Bonnard M, et al. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J Exp Med. 2000;191(10):1721–1734. doi:10.1084/jem.191.10.1721
   PubMed Web of Science ®Google Scholar
• Wu CM, Chen PC, Li TM, Fong YC, Tang CH. Si-Wu-tang extract stimulates bone formation through PI3K/Akt/NF-κB signaling pathways in osteoblasts. BMC Complement Altern Med. 2013;13:277. doi:10.1186/1472-6882-13-277
   PubMed Web of Science ®Google Scholar
• Peng XD, Xu PZ, Chen ML, et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 2003;17(11):1352–1365. doi:10.1101/gad.1089403
   PubMed Web of Science ®Google Scholar
• Adapala NS, Barbe MF, Tsygankov AY, Lorenzo JA, Sanjay A. Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b. J Cell Biochem. 2014;115(7):1277–1289. doi:10.1002/jcb.24779
   PubMed Web of Science ®Google Scholar
• Yu L, Jia D, Feng K, et al. A natural compound (LCA) isolated from Litsea cubeba inhibits RANKL-induced osteoclast differentiation by suppressing Akt and MAPK pathways in mouse bone marrow macrophages. J Ethnopharmacol. 2020;257:112873. doi:10.1016/j.jep.2020.112873
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu X, Li H, et al. Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway. Stem Cell Res Ther. 2016;7(1):136. doi:10.1186/s13287-016-0391-3
   PubMedGoogle Scholar